These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Cytomegalovirus infection and graft survival in renal graft recipients. Cappel R; Hestermans O; Toussaint C; Vereerstraeten P; van Beers D; de Braekeleer J; Schoutens E Arch Virol; 1978; 56(1-2):149-56. PubMed ID: 204269 [TBL] [Abstract][Full Text] [Related]
30. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran? Saghafi H; Qorashi M; Heidari A Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428 [TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus infections and toxoplasmosis in heart transplant recipients in Sweden. Andersson R; Sandberg T; Berglin E; Jeansson S Scand J Infect Dis; 1992; 24(4):411-7. PubMed ID: 1329187 [TBL] [Abstract][Full Text] [Related]
32. [Importance of screening for antibodies to cytomegalovirus in organ transplantation]. Milbradt H; Flik J; Stangel W; Heigel R Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866 [TBL] [Abstract][Full Text] [Related]
33. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients]. Eichler C; Kaden J; May G Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294 [TBL] [Abstract][Full Text] [Related]
34. Three-year experience with human cytomegalovirus infections in heart transplant recipients. Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498 [TBL] [Abstract][Full Text] [Related]
35. Incidence and predictive factors for cytomegalovirus infection in renal transplant recipients. Corona-Nakamura AL; Monteón-Ramos FJ; Troyo-Sanromán R; Arias-Merino MJ; Anaya-Prado R Transplant Proc; 2009; 41(6):2412-5. PubMed ID: 19715936 [TBL] [Abstract][Full Text] [Related]
36. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients]. Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566 [TBL] [Abstract][Full Text] [Related]
37. Opportunistic upper gastrointestinal infection in transplant recipients. Graham SM; Flowers JL; Schweitzer E; Bartlett ST; Imbembo AL Surg Endosc; 1995 Feb; 9(2):146-50. PubMed ID: 7597582 [TBL] [Abstract][Full Text] [Related]
38. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients]. Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666 [TBL] [Abstract][Full Text] [Related]